联影医疗
(688271)
| 流通市值：956.11亿 | | | 总市值：956.11亿 |
| 流通股本：8.24亿 | | | 总股本：8.24亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,907,566,494.56 | 13,800,251,663.95 | 8,858,916,392.73 | 6,015,901,402.16 |
| 营业收入 | 2,907,566,494.56 | 13,800,251,663.95 | 8,858,916,392.73 | 6,015,901,402.16 |
| 二、营业总成本 | 2,559,729,801.02 | 12,083,533,906.88 | 7,918,571,581.46 | 5,075,101,040.91 |
| 营业成本 | 1,536,316,521.02 | 7,312,582,446.96 | 4,693,777,044.5 | 3,132,664,301.76 |
| 税金及附加 | 16,885,670.78 | 71,322,317.07 | 48,407,236 | 30,107,015.65 |
| 销售费用 | 448,170,487.57 | 2,261,407,623.18 | 1,522,649,084.89 | 938,304,878.27 |
| 管理费用 | 138,422,825.87 | 626,904,263.9 | 447,264,729.43 | 257,182,484.27 |
| 研发费用 | 377,950,276.05 | 1,841,943,294.35 | 1,250,296,831.18 | 766,458,924.01 |
| 财务费用 | 41,984,019.73 | -30,626,038.58 | -43,823,344.54 | -49,616,563.05 |
| 其中:利息费用 | 6,453,248.12 | 18,769,868 | 12,749,994.04 | 5,292,016.92 |
| 其中:利息收入 | -16,628,678.28 | -85,727,321.21 | -64,558,314.78 | -44,496,516.79 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,181,436.71 | -37,113,946.49 | -41,816,402.32 | -45,441,421.76 |
| 加:投资收益 | 18,431,365.97 | 80,512,625.69 | 60,684,708.13 | 39,841,032.04 |
| 资产处置收益 | 270.61 | -641,405.91 | -641,241.48 | -640,729.77 |
| 资产减值损失(新) | -60,924.15 | 1,303,061.74 | 480,051.63 | -197,713.08 |
| 信用减值损失(新) | -39,140,889.79 | -194,450,990.75 | -96,889,157.34 | -72,911,342.79 |
| 其他收益 | 155,728,179.82 | 433,981,526.27 | 318,963,467.13 | 215,480,112.85 |
| 四、营业利润 | 485,976,132.71 | 2,000,308,627.62 | 1,181,126,237.02 | 1,076,930,298.74 |
| 加:营业外收入 | 428,433.66 | 6,189,198.45 | 4,587,989.54 | 2,148,497.13 |
| 减:营业外支出 | 5,285,373.54 | 25,102,821.54 | 7,161,500.29 | 6,106,665.13 |
| 五、利润总额 | 481,119,192.83 | 1,981,395,004.53 | 1,178,552,726.27 | 1,072,972,130.74 |
| 减:所得税费用 | 88,675,709.11 | 137,347,560.82 | 76,246,522.85 | 85,076,398.44 |
| 六、净利润 | 392,443,483.72 | 1,844,047,443.71 | 1,102,306,203.42 | 987,895,732.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 392,443,483.72 | 1,844,047,443.71 | 1,102,306,203.42 | 987,895,732.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 398,869,282.78 | 1,869,300,805.65 | 1,120,234,330 | 998,018,064.12 |
| 少数股东损益 | -6,425,799.06 | -25,253,361.94 | -17,928,126.58 | -10,122,331.82 |
| 扣除非经常损益后的净利润 | 371,861,638.8 | 1,769,843,181.21 | 1,053,226,533.66 | 965,612,481.04 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.48 | 2.28 | 1.36 | 1.21 |
| (二)稀释每股收益 | 0.48 | 2.28 | 1.36 | 1.21 |
| 八、其他综合收益 | -45,317,063.95 | -37,939,903.16 | -15,265,169.31 | -3,315,448.42 |
| 归属于母公司股东的其他综合收益 | -45,317,063.95 | -37,939,903.16 | -15,265,169.31 | -3,315,448.42 |
| 九、综合收益总额 | 347,126,419.77 | 1,806,107,540.55 | 1,087,041,034.11 | 984,580,283.88 |
| 归属于母公司股东的综合收益总额 | 353,552,218.83 | 1,831,360,902.49 | 1,104,969,160.69 | 994,702,615.7 |
| 归属于少数股东的综合收益总额 | -6,425,799.06 | -25,253,361.94 | -17,928,126.58 | -10,122,331.82 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |